Multidisciplinary Respiratory Medicine · 2011 · 18 citations · 5 references
MedicineImmunologyInternal MedicineMonoclonal AntibodiesPulmonologyRheumatologyAutoantibodiesAutoimmune Rheumatic DiseasesInterstitial Lung DiseaseInterstitial Lung Disease ImagingRespiratory DiseaseAnti-cd20 Antibody TherapyAnti-cd20 TherapyAnti-jo-1 AntibodiesAnti-ssa AntibodiesAntisynthetase SyndromeHigh-resolution TomographyInterstitial Lung Disease DetectionRituximab-based Therapy
We present a case of severe interstitial pneumonitis, mild polyarthritis and polymyositis, and Raynaud's syndrome with the presence of anti-Jo-1 antibodies, which had been diagnosed as anti-synthetase syndrome. The presence, however, of anti-Ro/SSA antibodies led us to understand that we were dealing here with a more severe form of interstitial lung disease. The patient was treated for acute respiratory failure but he showed resistance to glucocorticoids and cyclosporine. Thus, he was treated with infusions of anti-CD20 therapy (rituximab): his clinical conditions improved very rapidly and a significant decrease in the activity of pulmonary disease was detected using high-resolution computerized tomography (HRCT) of the thorax and pulmonary function tests.
5
Rituximab treatment of the anti-synthetase syndrome—a retrospective case series
Marthe Sem, Øyvind Molberg, May Brit Lund et al. · Lara D. Veeken · 2009 · 220 citations
Rituximab for refractory polymyositis: an open-label prospective study.
Chi Chiu Mok, Ling Yin Ho, Chi Hung To · PubMed · 2007 · 112 citations
Rituximab in life threatening antisynthetase syndrome
Elke Vandenbroucke, J.C. Grutters, Josje Altenburg et al. · Rheumatology International · 2009 · 69 citations